What's new
University of Oxford and Selvita collaborate to advance potential therapeutics for Parkinson's Disease
1 June 2023
The University of Oxford and Selvita (WSE: SLV), one of the largest contract research organisations in Europe, are collaborating on drug discovery in the area of Parkinson's disease
“Looking back on my childhood, I can’t ever remember a time when I didn’t feel negative."
22 May 2023
A data scientist who was able to return to work after taking medication for severe depression as part of an Oxford research trial has urged others to consider taking part in studies.
Brain and mental health innovation at Oxford
22 May 2023
Mental Health and Dementia are a global healthcare crisis, affecting over one billion people worldwide. Of those, over 400 million people are on the Alzheimer's disease continuum, with one person diagnosed every three seconds, and the figure expected to rise as the global population of those over 60 is set to double by 2050.